Federico García, PhD, is Head of the Microbiology Department at the University Hospital San Cecilio, Granada, Spain and Associate Professor in Microbiology at the University of Granada.
His current research activities include hepatitis B, C and delta virus, transmitted drug resistance in Spain and Europe, and clinical significance of HIV low- and very low-level viraemia.

Consultant Hepatologist at Egyptian Liver Research Institute and Hospital. I hold a PhD in Gastroenterology and Hepatology and am also a Lecturer in Gastroenterology and Hepatology Medicine. My research focuses particularly on HCC prediction and personalised surveillance, hepatitis elimination, non-invasive assessment of liver disease and innovative diagnostics for hepatitis C. I have led community-based hepatitis elimination initiatives, including the Educate, Test & Treat programme, and have contributed to numerous international publications and clinical trials.

Dr Rex Wan-Hin Hui is a clinician-scientist in The University of Hong Kong. He received his medical degree in 2018, graduating at the top of his class with the John Anderson Gold Medal. He completed his Hepatology specialty training and also completed his PhD in 2025.

Dr Hui's research focuses on risk prediction in hepatocellular carcinoma and hepatitis B. He has published over 75 articles, including articles in the Journal of Hepatology, Gut, Hepatology, and Clinical & Molecular Hepatology as lead author.

Physician scientist at Medical University of Vienna, Austria

Dr. Karim Seif El Dahan is a PGY-3 Internal Medicine resident at UT Southwestern Medical Center. His clinical and research interests include hepatocellular carcinoma surveillance, early detection, and strategies to improve patient outcomes. He aspires to pursue a career in academic gastroenterology and hepatology.

Dr. Junna is an Assistant Professor of Gastroenterology and Transplant Hepatology at the Cleveland Clinic. Her academic interests include liver transplantation, liver tumors, and DILI including ICI hepatitis and DI-ALH. She is currently the Medical Director of Transplant Oncology at the Cleveland Clinic and is passionate about advancing diagnostic and treatment modalities for primary liver cancers and CRLM, including increasing access to liver transplantation.